Iwasaki Wakana, Soma Hinata, Yamazaki Hiromichi, Zhang Bokun, Fukami Yohei, Tanaka Yasutake, Sato Masao, Nishimukai Megumi, Ishizuka Satoshi
Research Faculty of Agriculture, Hokkaido University, Sapporo, Japan.
Faculty of Agriculture, Kyushu University, Fukuoka, Japan.
Drug Metab Dispos. 2025 Jul;53(7):100095. doi: 10.1016/j.dmd.2025.100095. Epub 2025 May 12.
Oxidized sterols and redox status play an important role in the enhancement of lipid accumulation and exacerbation of symptoms in the liver. In this study, we examined whether the combination of dietary supplementation with cholesterol (Chol) and cholic acid (CA) modulates sterol metabolism and factors related to lipid accumulation in the liver. C57BL/6J male mice (4-week-old) were fed diets containing Chol at 3 g/kg and/or CA at 0.5 g/kg for 6 weeks. The lipid parameters, sterol metabolism, and hepatic gene expression were analyzed. An increase in hepatic triglyceride and fatty acid concentrations was observed in mice fed the Chol-supplemented diets. No additional effect of CA supplementation was observed on triglyceride concentration in the liver. Chol supplementation enhanced the fecal excretion of β-muricholic acid, whereas CA supplementation enhanced the circulation of enterohepatic 12-hydroxylated bile acids. Notably, the combination of dietary Chol and CA supplementation synergistically increased the concentrations of 4β-hydroxycholesterol and the gene expression of some inflammation-related factors in the liver. Similar changes were observed in the expression of ATP-binding cassette transporters (Abcg5 and Abcg8). The hepatic concentrations of some oxysterols, including 4β-hydroxycholesterol, were correlated with the expression of ATP-binding cassette transporters and glutathione S-transferases (Gsta1 and Gstm1). This suggests that the combination of dietary Chol and CA supplementation synergistically enhances Chol oxidation and proinflammatory events, accompanied by an alteration in the redox balance in the liver of mice, which may be an early symptom of liver disorders. SIGNIFICANCE STATEMENT: This study revealed that a combination of dietary cholesterol (Chol) and cholic acid (CA) supplementation synergistically increased oxysterol concentrations, muricholic acid excretion, and the expression of genes for inflammatory responses and Chol transport-related factors in the mouse liver. Chol increased the ratio of reduced glutathione/oxidized glutathione in the liver, whereas this ratio was modulated in combination with CA. This study highlights individual and synergistic roles of Chol and CA in Chol oxidation, bile acid metabolism, and inflammatory responses in the liver.
氧化甾醇和氧化还原状态在肝脏脂质积累增加和症状加重过程中发挥重要作用。在本研究中,我们检测了饮食中补充胆固醇(Chol)和胆酸(CA)的组合是否会调节甾醇代谢以及与肝脏脂质积累相关的因子。给4周龄的C57BL/6J雄性小鼠喂食含3 g/kg Chol和/或0.5 g/kg CA的饲料,持续6周。分析脂质参数、甾醇代谢和肝脏基因表达。在喂食补充Chol饲料的小鼠中观察到肝脏甘油三酯和脂肪酸浓度增加。未观察到补充CA对肝脏甘油三酯浓度有额外影响。补充Chol可增加β-鼠胆酸的粪便排泄,而补充CA可增加肠肝循环中12-羟基化胆汁酸的循环。值得注意的是,饮食中Chol和CA补充剂的组合协同增加了4β-羟基胆固醇的浓度以及肝脏中一些炎症相关因子的基因表达。在ATP结合盒转运蛋白(Abcg5和Abcg8)的表达中也观察到类似变化。包括4β-羟基胆固醇在内的一些氧化甾醇的肝脏浓度与ATP结合盒转运蛋白和谷胱甘肽S-转移酶(Gsta1和Gstm1)的表达相关。这表明饮食中Chol和CA补充剂的组合协同增强了Chol氧化和促炎事件,同时伴随着小鼠肝脏氧化还原平衡的改变,这可能是肝脏疾病的早期症状。意义声明:本研究表明,饮食中胆固醇(Chol)和胆酸(CA)补充剂的组合协同增加了氧化甾醇浓度、鼠胆酸排泄以及小鼠肝脏中炎症反应和Chol转运相关因子的基因表达。Chol增加了肝脏中还原型谷胱甘肽/氧化型谷胱甘肽的比例,而该比例在与CA联合使用时受到调节。本研究突出了Chol和CA在肝脏Chol氧化、胆汁酸代谢和炎症反应中的个体和协同作用。